The Hemodynamic and Neurohormonal Effects of Low Doses of Tezosentan (An Endothelin A/B Receptor Antagonist) in Patients with Acute Heart Failure
Gad Cotter(Assaf Harofeh Medical Center), Guillermo Torre‐Amione(Cornell University), Maurizio Rainisio(Actelion (Switzerland)), Loı̈c Perchenet(Actelion (Switzerland)), Isaac Kobrin(Actelion (Switzerland)), Olga Milo‐Cotter(Assaf Harofeh Medical Center), Christoph Richter(University of Vienna), Jasper Dingemanse(Actelion (Switzerland)), Aline Frey(Actelion (Switzerland)), Eric Neuhart(Actelion (Switzerland)), Shoshana Kaplan(Assaf Harofeh Medical Center), Zvi Vered(Assaf Harofeh Medical Center), Edo Kaluski(Assaf Harofeh Medical Center), Karl Stangl(Humboldt-Universität zu Berlin), Richard Pacher(University of Vienna)
Cited by 58
Related Papers
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial
|The Lancet|2018|734
A Constituent of Green Tea, Epigallocatechin-3-gallate, Activates Endothelial Nitric Oxide Synthase by a Phosphatidylinositol-3-OH-kinase-, cAMP-dependent Protein Kinase-, and Akt-dependent Pathway and Leads to Endothelial-dependent Vasorelaxation
|Journal of Biological Chemistry|2004|332
Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study
|American Heart Journal|2002|323
Molecular targets of tea polyphenols in the cardiovascular system
|Cardiovascular Research|2006|241
The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells
|Biochemical and Biophysical Research Communications|2004|196